CM Life Sciences II Stock Forecast, Price & News

+0.18 (+1.40 %)
(As of 06/18/2021 12:00 AM ET)
Today's Range
50-Day Range N/A
52-Week Range
Volume27,297 shs
Average Volume12,405 shs
Market Capitalization$360.18 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive CMII News and Ratings via Email

Sign-up to receive the latest news and ratings for CM Life Sciences II and its competitors with MarketBeat's FREE daily newsletter.

About CM Life Sciences II

CM Life Sciences II Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the life sciences sector. The company was incorporated in 2020 and is based in New York, New York.


CM Life Sciences II (NASDAQ:CMII) Stock Price Down 4.6%
CM Life Sciences II (NASDAQ:CMII) Stock Price Down 4.6%
June 3, 2021 |
See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.00 out of 5 stars

Unclassified Sector

414th out of 541 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

CM Life Sciences II (NASDAQ:CMII) Frequently Asked Questions

What stocks does MarketBeat like better than CM Life Sciences II?

Wall Street analysts have given CM Life Sciences II a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but CM Life Sciences II wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are CM Life Sciences II's key executives?

CM Life Sciences II's management team includes the following people:
  • Mr. Eli Decatur Casdin, CEO & Director
  • Mr. Brian Emes, CFO & Sec. (Age 38)
  • Dr. Shaun Kevin Rodriguez, Chief Strategy Officer (Age 43)

Who are some of CM Life Sciences II's key competitors?

What is CM Life Sciences II's stock symbol?

CM Life Sciences II trades on the NASDAQ under the ticker symbol "CMII."

How do I buy shares of CM Life Sciences II?

Shares of CMII can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CM Life Sciences II's stock price today?

One share of CMII stock can currently be purchased for approximately $13.05.

How much money does CM Life Sciences II make?

CM Life Sciences II has a market capitalization of $360.18 million.

How can I contact CM Life Sciences II?

The company can be reached via phone at 212 474 6745.

This page was last updated on 6/18/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.